Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

11. Juni 2009 10:06 ET | Quelle: Enobia Pharma Inc.

Enobia Announces Positive Interim Clinical Results With ENB-0040

MONTREAL, June 11, 2009 (GLOBE NEWSWIRE) -- Enobia Pharma, an emerging biotech company focused on developing novel therapeutics for serious bone disorders, announced that results from two early-stage...
11. Juni 2009 10:06 ET | Quelle: Enobia Pharma Inc.

Experimental Drug Strengthens Bones in Infants With Severe Hypophosphatasia

Shriners Hospitals for Children's Dr. Michael Whyte Presents First Efficacy and Safety Results of Targeted Enzyme Replacement Therapy in Patients With Rare Genetic Bone Disease ...
19. Mai 2009 09:58 ET | Quelle: Enobia Pharma Inc.

Enobia Pharma's ENB-0040 Receives FDA Fast Track Designation

MONTREAL, May 19, 2009 (GLOBE NEWSWIRE) -- Enobia Pharma, an emerging biotech company focused on developing novel therapeutics for serious bone disorders, announced that the U.S. Food and Drug...